Inovalon Mergers and Acquisitions Presentation Deck

Increasing Client-Base Diversification Inovalon 2017 1% 15% 15% 69% Payer INOV & ABILITY Presentation (3.7.18) v1.0.0 ABILITY 2017 Provider 9% 91% Pharma Devices Pro-Forma 2017 1% 34% 11% Note: Based on financial results of Inovalon (audited) and ABILITY (unaudited). Pro-forma results based on the combination of Inovalon and ABILITY without any adjustments. Graphics do not depict category 'other, which is de minimis. 54% 30

View entire presentation